1786.TW · SVBI
Taiwan · RS rating 2 · As of 2026-10-08
| Price | 41.70 TWD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 7 / 4 / 2 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 13 / 43 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +62.1% |
| Sales growth Q/Q | +2.8% |
| Distance from 52-week high | +62.3% |
| Market cap (USD) | $97.2M |